Post-traumatic stress disorder (PTSD) is a psychiatric condition developing after exposure to actual or threatened death, serious injury, or sexual violence — either directly, witnessed, or through repeated indirect exposure. It affects approximately 7–8% of the general population at some point in their lives and is particularly prevalent in South Africa, where high rates of violent crime, sexual assault, motor vehicle accidents, and community violence create frequent traumatic exposures. PTSD is a serious, potentially disabling condition — but it is also one of the most treatment-responsive major psychiatric disorders when appropriate evidence-based care is accessed early. This factsheet addresses the medical aid framework, including the mental-health PMB that is the primary coverage mechanism.
What Is PTSD?
PTSD develops after traumatic exposure in a subset of individuals (approximately 10–20% of those exposed). It is characterised by four symptom clusters:
Intrusion symptoms: - Recurrent, involuntary, distressing memories of the traumatic event - Flashbacks — dissociative episodes during which the person feels or acts as if the trauma is recurring - Distressing dreams with content related to the traumatic event
Avoidance: - Avoidance of trauma-related thoughts, feelings, or reminders - Avoidance of external reminders (people, places, activities, situations)
Negative alterations in cognition and mood: - Persistent negative beliefs about oneself or the world - Persistent negative emotional states (fear, horror, anger, guilt, shame) - Diminished interest in previously meaningful activities - Emotional numbing; inability to experience positive emotions
Arousal and reactivity alterations: - Irritability and angry outbursts - Hypervigilance - Exaggerated startle response - Sleep disturbance (difficulty falling or staying asleep) - Difficulty concentrating
PTSD may co-exist with depression, anxiety, substance use disorders, and chronic pain — conditions that each have their own benefit implications.
The Mental-Health PMB: Your Core Coverage Right
PTSD is a qualifying mental health condition under the mental-health PMB — it maps to the acute stress disorder DTP (code 901T) — which requires schemes to fund:
- Up to 3 days of hospital admission for medical/psychotherapy and counselling — funded at the PMB tariff without monetary limit (though specialist shortfalls apply), OR
- Up to 12 outpatient psychotherapy/counselling contacts in lieu of admission — funded at the approved tariff
This is a minimum benefit. Some plans exceed this — for example, providing 30 inpatient days or unlimited outpatient visits on comprehensive options. The Check shows what each plan on our panel pays for this, side by side, and Eldon advises from there.
The mental-health PMB covers assessment and treatment of PTSD — including psychiatrist review, psychological therapy, and acute hospitalisation when the severity warrants it.
Treatment: The Evidence Base
PTSD treatment combines pharmacotherapy and evidence-based psychological therapies. Neither is sufficient alone for most patients with moderate-to-severe PTSD.
First-line pharmacotherapy:
Sertraline (Zoloft, 50–200mg daily): SAHPRA-registered for PTSD; the most widely used SSRI for PTSD in SA; good evidence; generally well-tolerated. Monthly cost: R200–R300.
Paroxetine (Seroxat, 20–50mg daily): Also SAHPRA-registered for PTSD; similar efficacy to sertraline; more sedating (useful if insomnia is prominent). Monthly cost: R250–R350.
Venlafaxine (Efexor, 75–225mg daily): SNRI; effective second-line; useful when depression and anxiety are co-morbid. Monthly cost: R500–R700.
For trauma-related nightmares:
Prazosin (1–15mg nocte): Alpha-1 adrenergic antagonist; well-evidenced for reducing trauma nightmares; inexpensive; used off-label. Monthly cost: R100–R200.
For sleep and hyperarousal:
Mirtazapine: Sedating antidepressant; useful adjunct when insomnia is severe. R300–R400/month. Quetiapine (low dose): Atypical antipsychotic; useful adjunct for sleep; used at sub-antipsychotic doses (25–50mg). R400–R600/month.
Psychological Therapies: First-Line Treatment
Trauma-focused CBT (TF-CBT): The most robustly evidenced psychological treatment for PTSD. Structured; typically 12–16 sessions; includes psychoeducation about PTSD, relaxation, cognitive restructuring of trauma-related cognitions, and graduated exposure to trauma memories. Delivered by a trained clinical psychologist.
EMDR (Eye Movement Desensitisation and Reprocessing): An evidence-based treatment that uses bilateral stimulation (eye movements, taps, or tones) during trauma memory processing to reduce the distress associated with traumatic memories. Rapidly effective for single-incident trauma; typically 6–12 sessions. EMDR is listed in WHO guidelines and multiple national PTSD treatment guidelines.
Prolonged Exposure (PE): Structured exposure therapy protocol; gradual in vivo and imaginal exposure to trauma memories and triggers; 10–15 sessions.
Coverage of specific therapy modalities: schemes cover psychological therapy through the mental health outpatient benefit but often do not specify modalities. EMDR and TF-CBT are generally fundable as "psychological therapy" without requiring specific modality approval. Confirm with your scheme whether EMDR requires pre-authorisation or a specific billing code.
Annual Cost Estimates
| Scenario | Estimated Annual Cost |
|---|---|
| Mild PTSD — SSRI + psychologist (12 PMB visits) | R10,000 – R20,000 |
| Moderate PTSD — intensive outpatient + pharmacotherapy | R20,000 – R45,000 |
| Severe PTSD — acute inpatient admission (up to 3 days PMB) + outpatient | R40,000 – R80,000 |
Gap Cover Relevance: Medium
Psychiatric inpatient admissions generate psychiatrist specialist shortfalls (R15,000–R40,000/admission). Gap cover is relevant when hospitalisation occurs. Most PTSD patients who are managed outpatient-only have modest gap exposure. Plans with enhanced mental health benefits (above the PMB baseline) are the primary differentiator.
Plan Selection: What Matters Most
For PTSD and mental health conditions generally:
- Mental health inpatient benefit: Above the PMB's 3 days for acute stress? 30 or 42 days is a meaningful differentiator for recurrent admissions.
- Mental health outpatient visits: Above the PMB's 12 contacts? 20 or unlimited visits dramatically changes the ability to receive a full course of TF-CBT or EMDR.
- Psychology benefit structure: Are psychologist visits covered under the mental health benefit or a separate allied health benefit?
- Network psychiatric facilities: Which private psychiatric facilities are in-network? Network status affects both quality of care access and specialist shortfall exposure.
What the PMB covers, in the regulation’s terms
- For acute stress disorder after recent significant trauma, the PMB is up to 3 days of hospital-based care, or up to 12 outpatient therapy sessions instead of an admission. It is one or the other, never both. (901T. Medical Schemes Act regulations, Annexure A; outpatient alternative from the CMS PMB guideline (v1, 30.09.2020).)
Talk to Eldon
See which plans pay for PTSD →
This page is general information about medical schemes. It is not medical advice: speak to a healthcare professional about your own treatment. Medical aid and gap cover advice is given by Eldon de Waal, a Supervised Representative of Approach Administration (FSP 23579).